Mechanistic Insights into Astragalus Membranaceus for Oral Submucosal Fibrosis: A Network Pharmacology and Experimental Approach
Astragalus membranaceus injection may suppress ARE-induced fibrosis by targeting EGFR and VEGFA, supporting its potential therapeutic role in the treatment of OSF.
Authors
- Ya-Hsin Cheng
- Cheng Chen (ORCID: https://orcid.org/0000-0001-5439-5421)
- Ruifang Gao (ORCID: https://orcid.org/0000-0002-5149-4587)
- Yonglian Wu (ORCID: https://orcid.org/0000-0003-1862-0454)
- Fang Zhang
Institutions
- Shanxi Medical University (CN)
- China Medical University (TW)
Publication Details
- Journal
- Current Pharmaceutical Design
- Published
- 2025-08-04
- DOI
- https://doi.org/10.2174/0113816128374420250707120128
- Citations
- 1
- Primary Topic
- Oral Health Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47